Studies have found that miR-501-3p promotes CRC progression via activation of Wnt/β catenin signaling (Wu et al., 2019), that miR-4319 suppresses CRC progression by targeting ABTB1 (Huang et al., 2019), and that miR-144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in CRC (Jiang et al., 2019). Here, ABTB1 is linked to colorectal carcinoma.